American Delirium Society
2021 Virtual Annual Conference 

Scientific Discovery to Real World Implementation

#ADS21Virtual

June 13-15, 2021 | Virtual

Program Co-Chairs:

Babar Khan, MD, MS 
2021 Program Co-Chair
Immediate Past President, American Delirium Society

Noll Campbell, PharmD, MS 
2021 Program Co-Chair

CLICK HERE to view the brochure.

CLICK HERE to Register

Pre-Conference (PC) pricing is for Sunday, June 13, 2021. Full Conference (FC) pricing includes the Pre-Conference and is for Sunday, June 13 - Tuesday, June 15, 2021

PC ONLY (ADS Member or Non-Member)  $100.00
FC (ADS Member) Physician  $250.00
FC (ADS Member) Non-Physician  $250.00
**FC (Non-Member) Physician $350.00
**FC (Non-Member) Non-Physician  $350.00
FC (ADS Member or Non-Member) Resident  $100.00
FC (ADS Member or Non-Member) Fellow  $100.00
FC (ADS Member or Non-Member) Trainee  $100.00
FC (ADS Member or Non-Member) Student  $100.00

**Includes one-year membership (January 1-December 31, 2021)

Welcome

Welcome to the American Delirium Society (ADS) 2021 Virtual Annual Conference! We are pleased to host a 3-day meeting experience, which is expected to draw more than 400 investigators, educators and clinicians from all spectrums of healthcare and around the globe! #ADS21Virtual is the destination for professionals dedicated to improving delirium care at every level of their career.

The ADS conference focuses on learning with a diverse group of attendees across many disciplines and countries – each and every one striving to learn together as we improve delirium care across all healthcare settings.

The conference offers more than 20 symposia, workshops and roundtables, multiple abstract sessions, a virtual poster session and a robust all-day pre-conference. Internationally recognized faculty will deliver cutting edge clinical and research presentations encompassing all aspects of delirium care. We are proud to say that there will be something for everyone!

Don’t miss the following important events:

  • A dynamic full-day pre-conference. Through interactive didactic sessions and delirium assessment training, this intense curriculum will provide you with the skills to make important practice changes at your institution.
  • Plenaries from internationally recognized translational, clinical and policy experts.
  • Workshops and roundtables focused on practice improvement, education, research design/biostatistics, NIH funding and translational research.
  • Symposia focused on imaging, biomarkers, ICU practice change, sleep, palliative care, pediatrics and post-operative delirium prevention.
  • The NIDUS investigators will provide an update on their efforts to boost research infrastructure and training.
  • Presentations of oral abstracts moderated by senior investigators in the field.
  • A poster session moderated by experts in the field.

Finally, we wish to acknowledge the hard work and outstanding efforts of the Conference Planning Committee. A full list of committee members can be found below.

We welcome you to the ADS 2021 Virtual Annual Conference and hope you take advantage of all ADS has to offer.

Learning Objectives

  1. Identify evidence-based best practices for recognizing and assessing delirium among patients in hospital, outpatient, and long-term care settings.

  2. Discuss evidence-based preventative and therapeutic strategies for reducing the prevalence and duration of delirium across the continuum of care.

  3. Review novel and innovative strategies to develop, implement, evaluate and sustain health system delirium reduction efforts.

  4. Explain emerging and high-impact research focused on delirium epidemiology, pathophysiology, diagnosis, prevention and treatment.

2021 Conference Planning Committee

Babar Khan, MD, MS

Noll Campbell, PharmD, MS

Andrew Auerbach MD, MPH

Leanne Boehm, RN, PhD, ACNS-BC

Sikandar Khan, DO, MS

Heidi Lindroth, PhD, RN

Kerri Maya, MSL, RN, PHN

Esther Oh, MD, PhD

Mark Oldham, MD

Pratik Pandharipande, MD, MSCI, FCCM

Phillip Vlisides, MD

Christine Waszynski, DNP, APRN, GNP-BC

Schedule

PRE-CONFERENCE

SUNDAY, JUNE 13, 2021
Times listed in Eastern Standard Time (EST)

10:00-10:20am

Delirium: The Lived Experience

10:20-10:40am

Delirium: The State of the Science and Considerations for COVID

10:40-11:10am

Pathophysiology of Delirium and Associated Symptoms

11:10-11:30am

Outcomes Associated with Delirium

11:30am-12:00pm

Break

12:00-12:30pm

Delirium Nonpharmacologic and Pharmacologic Prevention and Management Strategies

12:30-1:00pm

Delirium Prevention and Management Breakout

• Pediatric
• ICU/Ward
• Long-term care

1:00-1:30pm

Break

1:30-3:30pm

Tools of the Trade: Delirium Assessment

• 1:30 PM Pediatric (pCAM-ICU) • 2:00 PM ICU (CAM-ICU)
• 2:30 PM Ward (3D-CAM)
• 3:00 PM Long-term care (FAM-CAM)

3:30-4:00pm

Bringing it all Together - Delirium Implementation & Strategy Breakout Session

4:00pm

Closing Comments and Adjournment

ANNUAL CONFERENCE

MONDAY, JUNE 14, 2021
Times listed in Eastern Standard Time (EST)

9:00-10:00am

ADS Committee Meetings

10:00-10:30am

Welcome: Presidential Address & Meeting Announcements

10:30-11:15am

Plenary: Leveraging Agile Implementation of Delirium Care Malaz Boustani, MD, MPH

11:20am-12:05pm

Plenary: Preclinical Delirium Models: Beauty and the Beast Roderic Eckenhoff, MD

12:05-12:35pm

Break

12:35-1:35pm

Workshop: Stats Part 1 - Improving the Design and Analysis of Delirium Trials

12:35-1:35pm

Symposium: Delirium and Serious Mental Illness

12:35-1:35pm

Symposium: Animal Models of Delirium: What Are We Measuring and is it Delirium?

12:35-1:35pm

Oral Abstracts 1

1:40-2:40pm

NIDUS Updates

1:40-2:40pm

Workshop: Delirium Management in the ICU

1:40-2:40pm

Anticholinergics and Delirium: Harmonizing Assessment

1:40-2:40pm

Symposium: Bundling Care: More than Cuddling in Pediatrics

2:45-3:45pm

NIDUS Pilots 1

2:45-3:45pm

Process Improvement in the ICU: Delirium Assessment and Management to Empower Bedside Caregivers

2:45-3:45pm

Symposium: Tackling Medication Management in the ICU and Beyond: Improving Patient Care Through Integration of Clinical Pharmacy Services

2:45-3:45pm

Delirium Monitoring and Management in the Busy Emergency Department

3:50-4:50pm

Optimizing Brain Health and Preventing Delirium Throughout the Perioperative Journey

3:50-4:50pm

Symposium: Novel Approaches for Managing Pain, Anxiety, Delirium and Sedation in the ICU

3:50-4:50pm

Symposium: Developing Current Clinical Phenotypes to Better Understand the Relationship Between Delirium and Dementia

3:50-4:50pm

Oral Abstracts 2

4:55-5:55pm

Symposium: Pain, Sleep and Cognition - Feasible Targets to Prevent Postoperative Delirium

4:55-5:55pm

Workshop: Statistical Consultation for Junior Clinical Investigators

4:55-5:55pm

Roundtable: Discussion of Cognitive and Behavioral Measurements in Delirium and its Relationship to Dementia

4:55-5:55pm

Oral Abstracts 3

TUESDAY, JUNE 15, 2021
Times listed in Eastern Standard Time (EST)

8:00-10:00am

Thematic Poster Discussion

10:00-10:30am

Announcements and Abstract Awards

10:30-11:15am

Plenary: New Horizons in Delirium Research Sharon Inouye, MD, MPH

11:20am-12:20pm

Delirium and COVID-19: State of the Science

12:20-12:50pm

Break

12:50-1:50pm

NIDUS Pilots 2

12:50-1:50pm

Symposium: Palliative Care and Delirium

12:50-1:50pm

Workshop: Delirium Pharmacoepidemiology: Application to Practice and Research

1:55-2:55pm

NIDUS Abstracts

1:55-2:55pm

Symposium: Perioperative Delirium: Pathogenesis, Screening and Management

1:55-2:55pm

Workshop: Delirium and Care Transitions: Delirium in the Nursing Home

3:00-4:00pm

NIH Updates

3:00-4:00pm

Symposium: Exploring the Relationship Between Sleep and Delirium in Critically Ill Patients and Examining the Results of a Two-Phase Study Assessing Implementation of a Sleep Protocol and a Validated Sleep Questionnaire

3:00-4:00pm

Roundtable: Expanding Delirium from the Binary to the Spectrum; the Importance of Severity Measurement in Future Delirium Research

4:05-5:05pm

Symposium: Stats Part 2 - Improving the Design and Analysis of Delirium Trials

4:05-5:05pm

Symposium: Unlocking the Network: Understanding Delirium Through Biomarkers of Neuroinflammation, Proteomics and DNA Damage

4:05-5:05pm

Definitions, Measures and Intervention Outcomes for Agitation During Illness and Medical Treatment

5:05-5:10pm

Closing Remarks

CE Credit

Physicians / Nurses / Pharmacists
           

In support of improving patient care, this activity has been planned and implemented by the American Delirium Society and Sutter Health. Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.